<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70905</article-id><article-id pub-id-type="doi">10.7554/eLife.70905</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Enrichment of <italic>SARM1 </italic>alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-240711"><name><surname>Gilley</surname><given-names>Jonathan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9510-7956</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-242476"><name><surname>Jackson</surname><given-names>Oscar</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1825-9331</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-242486"><name><surname>Pipis</surname><given-names>Menelaos</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242487"><name><surname>Estiar</surname><given-names>Mehrdad A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170270"><name><surname>Al-Chalabi</surname><given-names>Ammar</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258073"><name><surname>Danzi</surname><given-names>Matt C</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258074"><name><surname>van Eijk</surname><given-names>Kristel R</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242488"><name><surname>Goutman</surname><given-names>Stephen A</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242490"><name><surname>Harms</surname><given-names>Matthew B</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33715"><name><surname>Houlden</surname><given-names>Henry</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258075"><name><surname>Iacoangeli</surname><given-names>Alfredo</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218531"><name><surname>Kaye</surname><given-names>Julia</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242491"><name><surname>Lima</surname><given-names>Leandro</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242492"><name><surname>Ravits</surname><given-names>John</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-242493"><name><surname>Rouleau</surname><given-names>Guy A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195806"><name><surname>Schüle</surname><given-names>Rebecca</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-258076"><name><surname>Xu</surname><given-names>Jishu</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198634"><name><surname>Züchner</surname><given-names>Stephan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198764"><name><surname>Cooper-Knock</surname><given-names>Johnathan</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-175981"><name><surname>Gan-Or</surname><given-names>Ziv</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0332-234X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-76655"><name><surname>Reilly</surname><given-names>Mary M</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-139686"><name><surname>Coleman</surname><given-names>Michael P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><institution content-type="dept">Department of Clinical Neurosciences</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Department of Neuromuscular Disease</institution>, <institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution>McGill University</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff4"><institution>King's College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution>University of Miami Miller School of Medicine</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Neurology</institution>, <institution>Utrecht University</institution>, <addr-line><named-content content-type="city">Utrecht</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff7"><institution content-type="dept">Department of Neurology</institution>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution>Columbia University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Department of Molecular Neuroscience</institution>, <institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff10"><institution content-type="dept">Gladstone Institute of Neurological Disease</institution>, <institution>Gladstone Institutes</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff11"><institution>University of California, San Diego</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><aff id="aff12"><institution>University of Tübingen</institution>, <addr-line><named-content content-type="city">Tübingen</named-content></addr-line>, <country>Germany</country></aff><aff id="aff13"><institution>University of Sheffield</institution>, <addr-line><named-content content-type="city">Sheffield</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff14"><institution content-type="dept">MRC Centre for Neuromuscular Diseases</institution>, <institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-16110"><name><surname>Taylor</surname><given-names>J Paul</given-names></name><role>Reviewing editor</role><aff><institution>St Jude Children's Research Hospital</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jg792@cam.ac.uk</email> (JG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>mc469@cam.ac.uk</email> (MC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>11</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e70905</elocation-id><history><date date-type="received"><day>02</day><month>06</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>11</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Gilley et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Gilley et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70905-v2.pdf"/><abstract><p>SARM1, a protein with critical NADase activity, is a central executioner in a conserved programme of axon degeneration. We report seven rare missense or in-frame microdeletion human <italic>SARM1</italic> variant alleles in patients with amyotrophic lateral sclerosis (ALS) or other motor nerve disorders that alter the SARM1 auto-inhibitory ARM domain and constitutively hyperactivate SARM1 NADase activity. The constitutive NADase activity of these seven variants is similar to that of SARM1 lacking the entire ARM domain and greatly exceeds the activity of wild-type SARM1, even in the presence of nicotinamide mononucleotide (NMN), its physiological activator. This rise in constitutive activity alone is enough to promote neuronal degeneration in response to otherwise non-harmful, mild stress. Importantly, these strong gain-of-function alleles are completely patient-specific in the cohorts studied and show a highly significant association with disease at the single gene level. These findings of disease-associated coding variants that alter SARM1 function build on previously reported genome-wide significant association with ALS for a neighbouring, more common <italic>SARM1</italic> intragenic single nucleotide polymorphism (SNP) to support a contributory role of SARM1 in these disorders. A broad phenotypic heterogeneity and variable age-of-onset of disease among patients with these alleles also raises intriguing questions about the pathogenic mechanism of hyperactive SARM1 variants.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/S009582/1</award-id><principal-award-recipient><name><surname>Gilley</surname><given-names>Jonathan</given-names></name><name><surname>Jackson</surname><given-names>Oscar</given-names></name><name><surname>Coleman</surname><given-names>Michael P</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013278</institution-id><institution>EU Joint Programme – Neurodegenerative Disease Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Al-Chalabi</surname><given-names>Ammar</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012312</institution-id><institution>Robert Packard Center for ALS Research, Johns Hopkins University</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gilley</surname><given-names>Jonathan</given-names></name><name><surname>Coleman</surname><given-names>Michael P</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>216596/Z/19/Z</award-id><principal-award-recipient><name><surname>Cooper-Knock</surname><given-names>Johnathan</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>220906/Z/20/Z</award-id><principal-award-recipient><name><surname>Gilley</surname><given-names>Jonathan</given-names></name><name><surname>Jackson</surname><given-names>Oscar</given-names></name><name><surname>Pipis</surname><given-names>Menelaos</given-names></name><name><surname>Reilly</surname><given-names>Mary M</given-names></name><name><surname>Coleman</surname><given-names>Michael P</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>National Institutes of Neurological Diseases and Stroke and office of Rare Diseases</institution></institution-wrap></funding-source><award-id>U54NS065712</award-id><principal-award-recipient><name><surname>Pipis</surname><given-names>Menelaos</given-names></name><name><surname>Reilly</surname><given-names>Mary M</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>5R01NS072248-10 and 5R01NS105755-03</award-id><principal-award-recipient><name><surname>Danzi</surname><given-names>Matt C</given-names></name><name><surname>Züchner</surname><given-names>Stephan</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/L501529/1 and MR/R024804/1</award-id><principal-award-recipient><name><surname>Al-Chalabi</surname><given-names>Ammar</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000269</institution-id><institution>Economic and Social Research Council</institution></institution-wrap></funding-source><award-id>ES/L008238/1</award-id><principal-award-recipient><name><surname>Al-Chalabi</surname><given-names>Ammar</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000066</institution-id><institution>National Institute of Environmental Health Sciences</institution></institution-wrap></funding-source><award-id>K23ES027221</award-id><principal-award-recipient><name><surname>Goutman</surname><given-names>Stephen A</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000406</institution-id><institution>Motor Neurone Disease Association</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Al-Chalabi</surname><given-names>Ammar</given-names></name><name><surname>Iacoangeli</surname><given-names>Alfredo</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution>NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Al-Chalabi</surname><given-names>Ammar</given-names></name><name><surname>Iacoangeli</surname><given-names>Alfredo</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Jonathan Gilley, Part-funded by AstraZeneca during the past 3 years..</p></fn><fn fn-type="conflict" id="conf3"><p>Oscar Jackson, Currently part-funded by AstraZeneca..</p></fn><fn fn-type="conflict" id="conf4"><p>Michael P Coleman, Consults for Nura Bio, but no support provided for this work..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This is a retrospective study using anonymised data so specific consent was not obtained by the authors, but informed consent and consent to publish was obtained at each site that contributed patient information to this study in accordance with their local Institutional Review Boards (IRBs).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Genomic data was requested from a variety of previously published datasets from whom interested researchers can request access: Project MinE (https://www.projectmine.com/research/data-sharing/); Answer ALS (https://www.nygenome.org/als-consortium/); GENESIS (https://neuropathycommons.org/genetics/genesis-platform); UCL rare disease (neurology) dataset (available on request from Prof. Henry Houlden); HSP study (available on request from Dr. Rebecca Schüle); Lothian Birth Cohort (https://www.ed.ac.uk/lothian-birth-cohorts/data-access-collaboration). Further information about how to gain access to these datasets and any restrictions on who can gain access to the data is provided on these websites. The specifics of the datasets used are outlined in the Materials and Methods section, and are listed in Tables 1-4. Source data files of processed numerical data and raw blot images have been provided for Figures 2, 3, 4, 5, 6 and 7 and Figure 2 - figure supplement 2, Figure 3 - figure supplement 2 and Figure 6 - figure supplements 1 and 2.</p></sec><supplementary-material><ext-link xlink:href="elife-70905-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>